T2 Biosystms Alpha and Beta Analysis
| TTOODelisted Stock | USD 0.18 0.05 21.74% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as T2 Biosystms. It also helps investors analyze the systematic and unsystematic risks associated with investing in T2 Biosystms over a specified time horizon. Remember, high T2 Biosystms' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to T2 Biosystms' market risk premium analysis include:
Beta (4.31) | Alpha (0.78) | Risk 23.9 | Sharpe Ratio 0.0188 | Expected Return 0.45 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
TTOO |
T2 Biosystms Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. T2 Biosystms market risk premium is the additional return an investor will receive from holding T2 Biosystms long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in T2 Biosystms. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate T2 Biosystms' performance over market.| α | -0.78 | β | -4.31 |
T2 Biosystms Fundamentals Vs Peers
Comparing T2 Biosystms' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze T2 Biosystms' direct or indirect competition across all of the common fundamentals between T2 Biosystms and the related equities. This way, we can detect undervalued stocks with similar characteristics as T2 Biosystms or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of T2 Biosystms' fundamental indicators could also be used in its relative valuation, which is a method of valuing T2 Biosystms by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare T2 Biosystms to competition |
| Fundamentals | T2 Biosystms | Peer Average |
| Return On Equity | -6.22 | -0.31 |
| Return On Asset | -0.9 | -0.14 |
| Operating Margin | (4.91) % | (5.51) % |
| Current Valuation | 21.91 M | 16.62 B |
| Shares Outstanding | 21.04 M | 571.82 M |
| Shares Owned By Insiders | 10.17 % | 10.09 % |
| Shares Owned By Institutions | 73.51 % | 39.21 % |
T2 Biosystms Opportunities
T2 Biosystms Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About T2 Biosystms Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including TTOO or other pink sheets. Alpha measures the amount that position in T2 Biosystms has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
T2 Biosystms Upcoming Company Events
As portrayed in its financial statements, the presentation of T2 Biosystms' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, T2 Biosystms' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of T2 Biosystms' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of T2 Biosystms. Please utilize our Beneish M Score to check the likelihood of T2 Biosystms' management manipulating its earnings.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with T2 Biosystms
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystms check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystms' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |